GNOM.L vs. GNOG.L
GNOM.L (Global X Genomics & Biotechnology UCITS ETF) and GNOG.L (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds from Global X - GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF while GNOG.L tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 3 years, GNOM.L returned 4.58%/yr vs 5.11%/yr for GNOG.L. With a 0.96 correlation, they move nearly in lockstep. Both charge a 0.50% expense ratio.
Performance
GNOM.L vs. GNOG.L - Performance Comparison
Loading charts...
Different Trading Currencies
GNOM.L is traded in USD, while GNOG.L is traded in GBP. To make them comparable, the GNOG.L values have been converted to USD using the latest available exchange rates.
Returns By Period
The year-to-date returns for both investments are quite close, with GNOM.L having a 22.10% return and GNOG.L slightly higher at 22.32%.
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
GNOG.L
- 1D
- 0.46%
- 1M
- 12.17%
- 6M
- 15.97%
- YTD
- 22.32%
- 1Y
- 63.49%
- 3Y*
- 5.11%
- 5Y*
- —
- 10Y*
- —
GNOM.L vs. GNOG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | 22.32% | 20.47% | -18.41% | -6.60% | -37.25% | -32.56% |
Correlation
The correlation between GNOM.L and GNOG.L is 0.96 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.96 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.96 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.96 |
The correlation between GNOM.L and GNOG.L has been stable across timeframes, ranging from 0.96 to 0.96 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM.L vs. GNOG.L — Risk / Return Rank
GNOM.L
GNOG.L
GNOM.L vs. GNOG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GNOM.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GNOM.L | GNOG.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.07 | ||
| Sortino ratioReturn per unit of downside risk | 0.00 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.35 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | 3.34 | +0.01 |
| Martin ratioReturn relative to average drawdown | 9.16 | 9.08 | +0.08 |
Loading charts...
Drawdowns
GNOM.L vs. GNOG.L - Drawdown Comparison
The maximum GNOM.L drawdown since its inception was -69.32%, smaller than the maximum GNOG.L drawdown of -77.33%. Use the drawdown chart below to compare losses from any high point for GNOM.L and GNOG.L.
Loading charts...
Drawdown Indicators
| GNOM.L | GNOG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.32% | -77.33% | +8.01% |
Max Drawdown (1Y)Largest decline over 1 year | -18.91% | -18.91% | 0.00% |
Max Drawdown (3Y)Largest decline over 3 years | -44.77% | -44.90% | +0.13% |
Current DrawdownCurrent decline from peak | -37.11% | -53.57% | +16.46% |
Average DrawdownAverage peak-to-trough decline | -47.16% | -61.00% | +13.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.92% | 6.97% | -0.05% |
Volatility
GNOM.L vs. GNOG.L - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a higher volatility of 8.41% compared to Global X Genomics & Biotechnology UCITS ETF (GNOG.L) at 7.87%. This indicates that GNOM.L's price experiences larger fluctuations and is considered to be riskier than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM.L | GNOG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 7.87% | +0.54% |
Volatility (6M)Calculated over the trailing 6-month period | 22.18% | 21.26% | +0.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.87% | 29.03% | +0.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.11% | 37.09% | -3.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.11% | 37.09% | -3.98% |
GNOM.L vs. GNOG.L - Expense Ratio Comparison
Both GNOM.L and GNOG.L have an expense ratio of 0.50%.
Dividends
GNOM.L vs. GNOG.L - Dividend Comparison
Neither GNOM.L nor GNOG.L has paid dividends to shareholders.
Frequently Asked Questions
With a correlation of 0.96, GNOM.L and GNOG.L move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
Both ETFs have the same 0.50% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
GNOM.L and GNOG.L have the same expense ratio: 0.50% per year.
GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF, while GNOG.L tracks MSCI World/Health Care NR USD.
Find the right allocation for GNOM.L and GNOG.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer